John Bogdanos

411 total citations
15 papers, 319 citations indexed

About

John Bogdanos is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John Bogdanos has authored 15 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John Bogdanos's work include Prostate Cancer Treatment and Research (9 papers), Bone health and treatments (7 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). John Bogdanos is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Bone health and treatments (7 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). John Bogdanos collaborates with scholars based in Greece, United States and Spain. John Bogdanos's co-authors include Dimitrios Karamanolakis, Constantine Milathianakis, Michael Koutsilieris, Constantine S. Mitsiades, Ρωξάνη Τέντα, Antigone Sourla, Peter Lembessis, Antonis Halapas, P.A. Androulakakis and M. Koutsilieris and has published in prestigious journals such as Clinical Cancer Research, British Journal of Urology and Endocrine Related Cancer.

In The Last Decade

John Bogdanos

15 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Bogdanos Greece 12 147 118 74 71 50 15 319
Dimitrios Karamanolakis Greece 13 173 1.2× 100 0.8× 78 1.1× 69 1.0× 57 1.1× 25 398
Constantine Milathianakis Greece 12 175 1.2× 134 1.1× 75 1.0× 83 1.2× 46 0.9× 18 334
Kazuaki Mutaguchi Japan 10 112 0.8× 89 0.8× 30 0.4× 118 1.7× 70 1.4× 19 346
George G. Klee United States 8 173 1.2× 67 0.6× 35 0.5× 84 1.2× 84 1.7× 8 384
E Goes Belgium 10 63 0.4× 138 1.2× 57 0.8× 132 1.9× 61 1.2× 19 435
Dilek Yavuzer Türkiye 13 154 1.0× 114 1.0× 52 0.7× 83 1.2× 192 3.8× 42 466
Michael Koutsilieris Greece 9 84 0.6× 97 0.8× 63 0.9× 97 1.4× 16 0.3× 21 308
Byeong‐Joo Noh South Korea 11 106 0.7× 101 0.9× 54 0.7× 86 1.2× 90 1.8× 30 327
Kanae Ono Japan 12 106 0.7× 59 0.5× 41 0.6× 146 2.1× 43 0.9× 19 360

Countries citing papers authored by John Bogdanos

Since Specialization
Citations

This map shows the geographic impact of John Bogdanos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Bogdanos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Bogdanos more than expected).

Fields of papers citing papers by John Bogdanos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Bogdanos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Bogdanos. The network helps show where John Bogdanos may publish in the future.

Co-authorship network of co-authors of John Bogdanos

This figure shows the co-authorship network connecting the top 25 collaborators of John Bogdanos. A scholar is included among the top collaborators of John Bogdanos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Bogdanos. John Bogdanos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Koutsilieris, Michael, Constantine Milathianakis, John Bogdanos, et al.. (2007). Combination of somatostatin analogues and dexamethasone (antisurvival‐factor concept) with luteinizing hormone‐releasing hormone in androgen ablation‐refractory prostate cancer with bone metastasis. British Journal of Urology. 100(s2). 60–62. 12 indexed citations
3.
Koutsilieris, Michael, John Bogdanos, Constantine Milathianakis, et al.. (2006). Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach. Expert Opinion on Investigational Drugs. 15(7). 795–804. 13 indexed citations
4.
Karamanolakis, Dimitrios, John Bogdanos, Constantine Milathianakis, et al.. (2006). Serum testosterone: A potentially adjunct screening test for the assessment of the risk of prostate cancer among men with modestly elevated PSA values (> or =3.0 and <10.0 ng/ml).. PubMed. 26(4B). 3159–66. 25 indexed citations
5.
Mitsiades, Constantine S., et al.. (2006). Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. zoledronate in patients with androgen ablation-refractory prostate cancer.. PubMed. 26(5B). 3693–700. 30 indexed citations
6.
Koutsilieris, M., C Mitsiades, John Bogdanos, et al.. (2006). RANDOMISED CONTROLLED CLINICAL TRIAL OF A COMBINATION OF SOMATOSTATIN ANALOG AND DEXAMETHASONE PLUS ZOLEDRONATE VS. ZOLEDRONATE IN PATIENTS WITH ANDROGEN ABLATION REFRACTORY PROSTATE CANCER. European Urology Supplements. 5(2). 93–93. 8 indexed citations
7.
Milathianakis, Constantine, John Bogdanos, & Dimitrios Karamanolakis. (2005). Morbidity of prophylactic inguinal lymphadenectomy with saphenous vein preservation for squamous cell penile carcinoma. International Journal of Urology. 12(8). 776–778. 18 indexed citations
8.
Bogdanos, John, et al.. (2005). The large bladder diverticulum in children. Journal of Pediatric Urology. 1(4). 267–272. 22 indexed citations
9.
Bogdanos, John, et al.. (2004). Epoetin beta (NeoRecormon) corrects anaemia in patients with hormone-refractory prostate cancer and bone metastases.. PubMed. 24(3b). 1957–61. 20 indexed citations
10.
Koutsilieris, Michael, et al.. (2004). Combination of Somatostatin Analog, Dexamethasone, and Standard Androgen Ablation Therapy in Stage D3 Prostate Cancer Patients with Bone Metastases. Clinical Cancer Research. 10(13). 4398–4405. 39 indexed citations
11.
Bogdanos, John, Dimitrios Karamanolakis, Ρωξάνη Τέντα, et al.. (2003). Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton.. Endocrine Related Cancer. 10(2). 279–289. 58 indexed citations
12.
Bogdanos, John, et al.. (2003). Combined androgen blockade-induced anemia in prostate cancer patients without bone involvement.. PubMed. 23(2C). 1757–62. 19 indexed citations
13.
Bogdanos, John, Dimitrios Karamanolakis, Constantine Milathianakis, & Michael Koutsilieris. (2003). Syndrome of inappropriate antidiuretic hormone secretion in a patient with hormone refractory prostate cancer.. PubMed. 23(2C). 1755–6. 4 indexed citations
14.
Koutsilieris, Michael, Dimitrios Karamanolakis, John Bogdanos, et al.. (2002). Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer. Expert Opinion on Investigational Drugs. 11(2). 283–293. 18 indexed citations
15.
Karamanolakis, Dimitrios, John Bogdanos, Antigone Sourla, et al.. (2002). Molecular Evidence-Based Use of Bone Resorption-Targeted Therapy in Prostate Cancer Patients at High Risk for Bone Involvement. Molecular Medicine. 8(11). 667–675. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitrios Karamanolakis Breakdown of academic impact, for papers by Constantine Milathianakis Breakdown of academic impact, for papers by Kazuaki Mutaguchi Breakdown of academic impact, for papers by George G. Klee Breakdown of academic impact, for papers by E Goes Breakdown of academic impact, for papers by Dilek Yavuzer Breakdown of academic impact, for papers by Michael Koutsilieris Breakdown of academic impact, for papers by Byeong‐Joo Noh Breakdown of academic impact, for papers by Kanae Ono
Rankless by CCL
2026